ODSY Odyssey Healthcare (MM)

Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by members of the Board of Directors of Odyssey HealthCare, Inc. ("Odyssey" or the "Company") (NASDAQ: ODSY) in connection with their actions in causing Odyssey to enter into a definitive merger agreement to be acquired by Gentiva Health Services, Inc. ("Gentiva") (NASDAQ: GTIV). If the transaction is completed, Odyssey shareholders will receive $27.00 in cash for each share of Odyssey common stock they hold. The companies expect the transaction to close in the third quarter of 2010.

Robbins Umeda LLP's investigation concerns whether the Board of Directors of Odyssey undertook a fair process to obtain fair consideration for all shareholders of Odyssey. Of particular note is that the Company announced its first quarter earnings less than a month ago, on April 28, 2010. The Company stated that its diluted earnings per share for the quarter were $0.40, easily beating analyst estimates of $0.32 per share. As a result, many analysts dramatically increased their stock price targets for the Company.

If you are a shareholder of Odyssey and would like more information about your rights as a shareholder, please contact attorney Gregory E. Del Gaizo at 800-350-6003 or by e-mail at inquiry@robbinsumeda.com.

Robbins Umeda LLP is a California-based law firm with significant experience representing investors in merger-related shareholder class actions, shareholder derivative actions, and securities fraud class actions. For more information about the firm, please go to http://www.robbinsumeda.com.

Advertisement

Odyssey Healthcare (MM) (NASDAQ:ODSY)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Odyssey Healthcare (MM) (NASDAQ:ODSY)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024